In the English version of the pressrelease from PExA AB published earlier part of the text was missing. Here follows the corrected version:
Swedish medical technology company PExA AB (“PExA”) announced that it has entered into a research collaboration agreement with
Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the University of Gothenburg.
PExA, which focuses on the development and commercialization of a unique breath sampling technology for biomarker discovery, was recently selected Awardee of the Carcinogenic Exposure Meter